These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 34626362)

  • 41. CAR-T cells and allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia.
    Liu J; Zhang X; Zhong JF; Zhang C
    Immunotherapy; 2017 Oct; 9(13):1115-1125. PubMed ID: 29032733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Maintenance therapy following CD19 CAR-T treatment for relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation].
    Jiang YL; Li Q; Pu YD; Jiang YY; Yuan T; Deng Q; Li YM; Han MZ; Zhai WH
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):495-501. PubMed ID: 32654464
    [No Abstract]   [Full Text] [Related]  

  • 43. Donor-Derived CD7 CAR-T Therapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Acute T-Lymphocytic Leukemia Associated With Hepatitis B: A Case Report.
    Li Z; Meng F; Li J; Wu T
    Front Immunol; 2022; 13():931452. PubMed ID: 35903089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How I treat adults with advanced acute lymphoblastic leukemia eligible for CD19-targeted immunotherapy.
    Aldoss I; Forman SJ
    Blood; 2020 Mar; 135(11):804-813. PubMed ID: 31899793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chimeric antigen receptor T-cell therapy for adult B-cell acute lymphoblastic leukemia: state-of-the-(C)ART and the road ahead.
    Pasvolsky O; Kebriaei P; Shah BD; Jabbour E; Jain N
    Blood Adv; 2023 Jul; 7(14):3350-3360. PubMed ID: 36912764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancing CD19 Chimeric Antigen Receptor T Cells Through Memory-Enriched T Cells.
    El Marabti E; Abdel-Wahab O
    Clin Cancer Res; 2023 Feb; 29(4):694-696. PubMed ID: 36507801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.
    Lee DW; Kochenderfer JN; Stetler-Stevenson M; Cui YK; Delbrook C; Feldman SA; Fry TJ; Orentas R; Sabatino M; Shah NN; Steinberg SM; Stroncek D; Tschernia N; Yuan C; Zhang H; Zhang L; Rosenberg SA; Wayne AS; Mackall CL
    Lancet; 2015 Feb; 385(9967):517-528. PubMed ID: 25319501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current status of CAR-T cell therapy for pediatric hematologic malignancies.
    Hiramatsu H
    Int J Clin Oncol; 2023 Jun; 28(6):729-735. PubMed ID: 37154980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [CAR-T CELL THERAPY FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH A LARGE OVARIAN EXTRAMEDULLARY MASS].
    Jacoby E; Toren A; Gefen R; Shapira A; Arad-Cohen N
    Harefuah; 2023 Jan; 162(1):15-18. PubMed ID: 36714936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [In vitro studies on the transfer of CAR into leukemia cells due to their residue in the autologous CAR-T cell preparation system for acute B-cell acute lymphoblastic leukemia].
    Liu MJ; Mu J; Yuan T; Cui R; Meng JX; Jiang YY; Li YM; Deng Q
    Zhonghua Xue Ye Xue Za Zhi; 2021 Feb; 42(2):140-145. PubMed ID: 33858045
    [No Abstract]   [Full Text] [Related]  

  • 51. Current Status of CAR T Cell Therapy for Leukemias.
    Harris K; LaBelle JL; Bishop MR
    Curr Treat Options Oncol; 2021 Jun; 22(7):62. PubMed ID: 34097135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CAR-T cell therapy in paediatric acute lymphoblastic leukaemia - past, present and future.
    Rogosic S; Ghorashian S
    Br J Haematol; 2020 Nov; 191(4):617-626. PubMed ID: 33190266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potent anti-leukemia activities of humanized CD19-targeted Chimeric antigen receptor T (CAR-T) cells in patients with relapsed/refractory acute lymphoblastic leukemia.
    Cao J; Wang G; Cheng H; Wei C; Qi K; Sang W; Zhenyu L; Shi M; Li H; Qiao J; Pan B; Zhao J; Wu Q; Zeng L; Niu M; Jing G; Zheng J; Xu K
    Am J Hematol; 2018 Jul; 93(7):851-858. PubMed ID: 29633386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of allogeneic haematopoietic cell transplantation as consolidation after anti-CD19 CAR-T cell therapy in adults with relapsed/refractory acute lymphoblastic leukaemia: a prospective cohort study.
    Han S; Zhou L; Chen Y; Zhou X; Guo Z; Yang J; Jin B; Liu Y; Chang LJ; Li Y; Tu S
    Bone Marrow Transplant; 2022 Mar; 57(3):513-516. PubMed ID: 35058582
    [No Abstract]   [Full Text] [Related]  

  • 55. CAR-T Cell Therapies: An Overview of Clinical Studies Supporting Their Approved Use against Acute Lymphoblastic Leukemia and Large B-Cell Lymphomas.
    Ahmad A; Uddin S; Steinhoff M
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486160
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes of CD19 chimeric antigen receptor T cell followed by haploidentical hematopoietic stem-cell transplantation in relapsed/refractory B-cell acute lymphoblastic leukemia with IKZF1 deletion.
    Ni F; Yin ETS; Zhou L; Zhao H; Luo Y; Shi J; Hu Y; Huang H
    Bone Marrow Transplant; 2022 Feb; 57(2):326-328. PubMed ID: 35067672
    [No Abstract]   [Full Text] [Related]  

  • 57. Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia.
    Zhao X; Wu H; Cheng Y; Xu Z; Chen Y; Chang Y; Wang Y; Zhang X; Xu L; Huang X
    Chin Med J (Engl); 2023 Aug; 136(16):2011-2013. PubMed ID: 37462037
    [No Abstract]   [Full Text] [Related]  

  • 58. Pseudoprogression of extramedullary disease in relapsed acute lymphoblastic leukemia after CAR T-cell therapy.
    Huang J; Rong L; Wang E; Fang Y
    Immunotherapy; 2021 Jan; 13(1):5-10. PubMed ID: 33045890
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of lymphoblastic leukemia with CD19-specific modified chimeric antigen receptor T cells].
    Li HH; Zhu P; Wu XQ; Liu YF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1753-6. PubMed ID: 25543510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia.
    Weng J; Lai P; Qin L; Lai Y; Jiang Z; Luo C; Huang X; Wu S; Shao D; Deng C; Huang L; Lu Z; Zhou M; Zeng L; Chen D; Wang Y; Chen X; Geng S; Robert W; Tang Z; He C; Li P; Du X
    J Hematol Oncol; 2018 Feb; 11(1):25. PubMed ID: 29458388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.